• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION CHARGER; CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION CHARGER; CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL Back to Search Results
Model Number 24681
Medical Device Problem Code Material Rupture (1546)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 11/16/2020
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that balloon rupture occurred.The 90% stenosed target lesion was located in the severely calcified and tortuous iliac artery.A 10.0 x80, 75cm charger balloon catheter was advanced for dilation.However, when the balloon was inflated at 14 atmospheres, contrast agent leakage was noted.The device was withdrawn and checked, and it was found that the balloon ruptured.The procedure was completed with another of same device.There were no patient complications reported and the patient was stable.
 
Event or Problem Description
It was reported that balloon rupture occurred.The 90% stenosed target lesion was located in the severely calcified and tortuous iliac artery.A 10.0 x80, 75cm charger balloon catheter was advanced for dilation.However, when the balloon was inflated at 14 atmospheres, contrast agent leakage was noted.The device was withdrawn and checked, and it was found that the balloon ruptured.The procedure was completed with another of same device.There were no patient complications reported and the patient was stable.
 
Additional Manufacturer Narrative
Device evaluated by mfr.: charger device - 10x80x75cm was received for analysis.A visual examination identified that the balloon was not folded which indicates that the balloon was subjected to positive pressure.A visual and microscopic examination identified a longitudinal tear in the balloon material beginning approximately at the proximal balloon bond and extending distally across the balloon material and ending approximately at the distal balloon bond.An examination of the balloon material and markerbands identified no issues which could potentially have contributed to this complaint.A visual and microscopic examination of the markerbands identified no issues which may potentially have contributed to the complaint incident.A visual and tactile examination identified no kinks or damage to the shaft which may have potentially contributed to the complaint incident.A visual and tactile examination identified damage.This type of damage is consistent with excessive force being applied to the device when attempting to cross a challenging lesion.No other issues were identified during the product analysis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CHARGER
Common Device Name
CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key11015369
Report Number2134265-2020-17615
Device Sequence Number3944428
Product Code FGE
UDI-Device Identifier08714729803812
UDI-Public08714729803812
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K112697
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 01/14/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date06/22/2023
Device Model Number24681
Device Catalogue Number24681
Device Lot Number0025621954
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/21/2020
Initial Date Received by Manufacturer 12/01/2020
Supplement Date Received by Manufacturer01/08/2021
Initial Report FDA Received Date12/16/2020
Supplement Report FDA Received Date01/14/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age68 YR
-
-